Vertical Pharms Drug Patent Portfolio

Vertical Pharms owns 1 orange book drug protected by 21 US patents Given below is the list of Vertical Pharms's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11672738 Apparatus and methods for dispensing oral transmucosal dosage forms 02 Feb, 2038
Active
US8945592 Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same 29 Jul, 2031
Active
US8202535 Small-volume oral transmucosal dosage forms 22 Oct, 2030
Active
US8865743 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain 22 Oct, 2030
Active
US10896751 Storage and dispensing devices for administration of oral transmucosal dosage forms 16 Mar, 2030
Active
US11676691 Storage and dispensing devices for administration of oral transmucosal dosage forms 16 Mar, 2030
Active
US12033733 Storage and dispensing devices for administration of oral transmucosal dosage forms 16 Mar, 2030
Active
US8574189 Storage and dispensing devices for administration of oral transmucosal dosage forms 16 Mar, 2030
Active
US10245228 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain 05 Jan, 2027
Active
US10342762 Small-volume oral transmucosal dosage forms 05 Jan, 2027
Active
US10507180 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain 05 Jan, 2027
Active
US8226978 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain 05 Jan, 2027
Active
US8231900 Small-volume oral transmucosal dosage 05 Jan, 2027
Active
US8252328 Bioadhesive drug formulations for oral transmucosal delivery 05 Jan, 2027
Active
US8252329 Bioadhesive drug formulations for oral transmucosal delivery 05 Jan, 2027
Active
US8535714 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain 05 Jan, 2027
Active
US8778393 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain 05 Jan, 2027
Active
US8778394 Small-volume oral transmucosal dosage forms 05 Jan, 2027
Active
US8865211 Bioadhesive drug formulations for oral transmucosal delivery 05 Jan, 2027
Active
US9320710 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain 05 Jan, 2027
Active
US9744129 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain 05 Jan, 2027
Active


Given below is the list of recent legal activities going on the following drug patents of Vertical Pharms.

Activity Date Patent Number
Patent litigations
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 12 Apr, 2024 US10896751
Payment of Maintenance Fee, 12th Year, Large Entity 28 Feb, 2024 US8252329
Payment of Maintenance Fee, 12th Year, Large Entity 28 Feb, 2024 US8252328
Payment of Maintenance Fee, 12th Year, Large Entity 31 Jan, 2024 US8231900
Payment of Maintenance Fee, 12th Year, Large Entity 24 Jan, 2024 US8226978
Email Notification 09 Jan, 2024 US8778393
Change in Power of Attorney (May Include Associate POA) 09 Jan, 2024 US8778393
Change in Power of Attorney (May Include Associate POA) 20 Dec, 2023 US8778393
Email Notification 20 Dec, 2023 US8778393
Mail O.P. Petition Decision 19 Dec, 2023 US11676691
Email Notification 19 Dec, 2023 US11676691
Payment of Maintenance Fee, 12th Year, Large Entity 19 Dec, 2023 US8202535
Change in Power of Attorney (May Include Associate POA) 18 Dec, 2023 US8778394
Email Notification 18 Dec, 2023 US8778394
Change in Power of Attorney (May Include Associate POA) 18 Dec, 2023 US8865211


Vertical Pharms's Family Patents

Vertical Pharms drugs have patent protection in a total of 19 countries. It's US patent count contributes only to 38.8% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Vertical Pharms Drug List

Given below is the complete list of Vertical Pharms's drugs and the patents protecting them.


1. Dsuvia

Dsuvia is protected by 21 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11672738 Apparatus and methods for dispensing oral transmucosal dosage forms 02 Feb, 2038
(13 years from now)
Active
US8945592 Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same 29 Jul, 2031
(6 years from now)
Active
US8202535 Small-volume oral transmucosal dosage forms 22 Oct, 2030
(6 years from now)
Active
US8865743 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain 22 Oct, 2030
(6 years from now)
Active
US10896751 Storage and dispensing devices for administration of oral transmucosal dosage forms 16 Mar, 2030
(5 years from now)
Active
US11676691 Storage and dispensing devices for administration of oral transmucosal dosage forms 16 Mar, 2030
(5 years from now)
Active
US12033733 Storage and dispensing devices for administration of oral transmucosal dosage forms 16 Mar, 2030
(5 years from now)
Active
US8574189 Storage and dispensing devices for administration of oral transmucosal dosage forms 16 Mar, 2030
(5 years from now)
Active
US10245228 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain 05 Jan, 2027
(2 years from now)
Active
US10342762 Small-volume oral transmucosal dosage forms 05 Jan, 2027
(2 years from now)
Active
US10507180 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain 05 Jan, 2027
(2 years from now)
Active
US8226978 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain 05 Jan, 2027
(2 years from now)
Active
US8231900 Small-volume oral transmucosal dosage 05 Jan, 2027
(2 years from now)
Active
US8252328 Bioadhesive drug formulations for oral transmucosal delivery 05 Jan, 2027
(2 years from now)
Active
US8252329 Bioadhesive drug formulations for oral transmucosal delivery 05 Jan, 2027
(2 years from now)
Active
US8535714 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain 05 Jan, 2027
(2 years from now)
Active
US8778393 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain 05 Jan, 2027
(2 years from now)
Active
US8778394 Small-volume oral transmucosal dosage forms 05 Jan, 2027
(2 years from now)
Active
US8865211 Bioadhesive drug formulations for oral transmucosal delivery 05 Jan, 2027
(2 years from now)
Active
US9320710 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain 05 Jan, 2027
(2 years from now)
Active
US9744129 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain 05 Jan, 2027
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Dsuvia's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List